Search Results - "Kanlı,Aylin"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Changes occurring in the proteome of SH-SY5Y cells caused by fat mass and obesity associated (FTO) protein expression reveals multifaceted properties of the FTO protein by Kanlı,Aylin, Kasap,Murat, Akpınar,Gürler, Yanar,Sevinç

    “…Objective: Fat mass and obesity associated (FTO) protein is an RNA-demethylase which is employed in various metabolic functions such as post-transcriptional…”
    Get full text
    Journal Article
  2. 2

    Effect of resveratrol on chromosomal aberrations induced by doxorubicin in rat bone marrow cells by Bingöl, Günsel, Gülkaç, Mehmet Doğan, Dillioğlugil, Meltem Özlen, Polat, Fikriye, Kanli, Aylin Özön

    “…•RES has anticlastogenic effect in bone marrow cells induced by DXR.•Repeated doses of RES at 25mg/kgbw has protection on DXR-induced chromosomal…”
    Get full text
    Journal Article
  3. 3

    Effects of vitamin A on doxorubicin‐induced chromosomal aberrations in bone marrow cells of rats by Gülkaç, Mehmet Dogan, Akpinar, Gürler, Üstün, Hasan, Özön Kanli, Aylin

    Published in Mutagenesis (01-05-2004)
    “…The present study was carried out to evaluate the role of vitamin A (VA) on the induction of chromosomal aberrations (CA) in rat bone marrow cells and to…”
    Get full text
    Journal Article
  4. 4

    Comparative Proteome Analyses of Ureteropelvic Junction Obstruction and Surrounding Ureteral Tissue by Görmüş, Uzay, Kasap, Murat, Akpınar, Gürler, Tuğtepe, Halil, Kanlı, Aylin, Özel, Kerem

    Published in Cells, tissues, organs (2020)
    “…Ureteropelvic junction (UPJ) obstruction is a common problem in children, but its etiology remains unclear. In this study, the proteome profiles of the…”
    Get more information
    Journal Article
  5. 5

    Tümör Doku Heterojenitesinin 2DE Proteomik Yaklaşımıyla Gösterilmesi by Zafer Cantürk, Gürler Akpınar, Murat Kasap, Turgay Şimşek, Aylin Kanlı

    Published in Sakarya tıp dergisi (01-06-2022)
    “…Amaç: Birçok hastalığın ve kanserlerin biyolojik mekanizmalarının incelenmesinde yaygın olarak kullanılan proteomik yaklaşımlar, hastalık sürecinin…”
    Get full text
    Journal Article
  6. 6

    Protective effects of increasing vitamin E and a doses on cisplatin-induced oxidative damage to kidney tissue in rats by Dillioglugil, Meltem Ozlen, Maral Kir, Hale, Gulkac, Mehmet Dogan, Ozon Kanli, Aylin, Ozdogan, Haci Kahya, Acar, Oguz, Dillioglugil, Ozdal

    Published in Urologia internationalis (01-01-2005)
    “…Cisplatin (DDP, cis-diamminedichloroplatinium II) is one of the most potent chemotherapeutic antitumor drugs, but is able to generate reactive oxygen species…”
    Get more information
    Journal Article
  7. 7

    Proteomics analysis of meclofenamic acid‐treated small cell lung carcinoma cells revealed changes in cellular energy metabolism for cancer cell survival by Yanar, Sevinc, Kasap, Murat, Kanli, Aylin, Akpinar, Gurler, Sarihan, Mehmet

    “…Small cell lung carcinoma (SCLC) is a highly aggressive cancer with low survival rate. Although initial response to chemotherapy in SCLC patients is…”
    Get full text
    Journal Article
  8. 8

    Effect of aflibercept on proliferative vitreoretinopathy: Proteomic analysis in an experimental animal model by Uslubas, Isil, Kanli, Aylin, Kasap, Murat, Akpinar, Gurler, Karabas, Levent

    Published in Experimental eye research (01-02-2021)
    “…The aim of this study was to monitor inflammatory, proliferative and progressive effects of proliferative vitreoretinopathy (PVR) and aflibercept treatment in…”
    Get full text
    Journal Article
  9. 9

    Proteomic studies associated with Parkinson's disease by Kasap, Murat, Akpinar, Gurler, Kanli, Aylin

    Published in Expert review of proteomics (04-03-2017)
    “…Parkinson's disease (PD) is an insidious disorder affecting more than 1-2% of the population over the age of 65. Understanding the etiology of PD may create…”
    Get more information
    Journal Article
  10. 10

    Synergistic effect of a nonsteroidal anti-inflammatory drug in combination with topotecan on small cell lung cancer cells by Yanar, Sevinc, Kanli, Aylin, Kasap, Murat, Bal Albayrak, Merve Gulsen, Eskiler, Gamze Guney, Ozkan, Asuman Deveci

    Published in Molecular biology reports (01-12-2024)
    “…Background The topoisomerase I inhibitor topotecan (TPT) is used in the treatment of recurrent small cell lung cancer (SCLC). However, the drug has a limited…”
    Get full text
    Journal Article
  11. 11

    Investigation of the effect of meclofenamic acid on the proteome of LNCaP cells reveals changes in alternative polyadenylation and splicing machinery by Saglam, Busra Sahinoz, Kanli, Aylin, Yanar, Sevinc, Kasap, Murat, Akpinar, Gurler

    “…Prostate cancer is the most common type of cancer among men, and there is still no definitively effective drug treatment. Thus, the search for novel drug…”
    Get full text
    Journal Article
  12. 12

    Comparative Proteomics Analysis of Four Commonly Used Methods for Identification of Novel Plasma Membrane Proteins by Yoneten, Kubra Karaosmanoglu, Kasap, Murat, Akpinar, Gurler, Kanli, Aylin, Karaoz, Erdal

    Published in The Journal of membrane biology (01-12-2019)
    “…Plasma membrane proteins perform a variety of important tasks in the cells. These tasks can be diverse as carrying nutrients across the plasma membrane,…”
    Get full text
    Journal Article
  13. 13

    Proteomics analysis of pleomorphic adenoma of the human parotid gland by Mutlu, Ahmet, Ozturk, Murat, Akpinar, Gurler, Kasap, Murat, Kanli, Aylin

    Published in European archives of oto-rhino-laryngology (01-08-2017)
    “…The objective of this study is to perform proteomic analysis of pleomorphic adenoma (PA) in the human parotid gland (PG) with comparison of normal PG. This is…”
    Get full text
    Journal Article
  14. 14

    Identification of differentially regulated deceitful proteins in SH‐SY5Y cells engineered with Tet‐regulated protein expression system by Kanli, Aylin, Kasap, Murat, Yoneten, Kubra K., Akpinar, Gurler, Gulkac, Mehmet Dogan

    Published in Journal of cellular biochemistry (01-07-2018)
    “…Tetracycline regulated protein expression in mammalian cells is a powerful tool to predict the physiological function, cellular localization, and stability of…”
    Get full text
    Journal Article
  15. 15

    Linking a compound-heterozygous Parkin mutant (Q311R and A371T) to Parkinson's disease by using proteomic and molecular approaches by Ozgul, Sinem, Kasap, Murat, Akpinar, Gurler, Kanli, Aylin, Güzel, Nil, Karaosmanoglu, Kübra, Baykal, Ahmet Tarik, Iseri, Pervin

    Published in Neurochemistry international (01-06-2015)
    “…•Two inducible cell lines that expressed the WT and the mutant Parkin were created.•Biochemical properties of the WT and the mutant forms of Parkin were…”
    Get full text
    Journal Article
  16. 16

    Exogenous Expressions of FTO Wild-Type and R316Q Mutant Proteins Caused an Increase in HNRPK Levels in 3T3-L1 Cells as Demonstrated by DIGE Analysis by Gulkac, M. Dogan, Akpinar, Gurler, Kanli, Aylin, Kasap, Murat, Guzel, Nil, Karaosmanoglu, Kubra

    Published in BioMed research international (01-01-2017)
    “…Fat mass and obesity-associated protein is an enzyme that oxidatively demethylates DNA. Although there are numerous studies regarding the catalytic function of…”
    Get full text
    Journal Article
  17. 17

    The Demonstration of Tumor Heterogeneity using 2DE Proteomic Approach by KANLI, Aylin, ŞİMŞEK, Turgay, KASAP, Murat, AKPINAR, Gürler, CANTÜRK, Zafer

    Published in Sakarya tıp dergisi (07-04-2022)
    “…Objective: Proteomic approaches, have been used in monitoring the disease processes and identification of biomarkers. Biological samples used in the field of…”
    Get full text
    Journal Article
  18. 18

    Effects of 10alpha,25-dihydroxyvitamin D3 on doxorubicin-induced chromosomal aberrations in rat bone marrow cells by Kocak, Nilufer, Ustün, Hasan, Gülkaç, Mehmet Doğan, Kanli, Aylin Ozön, Borazan, Ali, Yilmaz, Ahmet

    Published in Acta oncologica (2004)
    “…The present study was carried out to evaluate the effects of 1alpha,25-dihydroxyvitamin D3 (VD) on chromosomal aberrations induced by doxorubicin (DXR). Wistar…”
    Get more information
    Journal Article